No cure available for exposure to potentially deadly ionizing radiation
- UVA researchers have identified compounds that could lead to the first antidote for potentially deadly radiation exposure
- Research was spurred by government concern about terror attacks and nuclear accidents
- For people exposed to sufficient ionizing radiation, doctors can only try to ease their suffering until death
- 2016 is the 30th anniversary of the Chernobyl nuclear accident and the fifth anniversary of the Fukushima nuclear accident
University of Virginia School of Medicine researchers have identified promising drugs that could lead to the first antidote for radiation exposure that might result from a dirty bomb terror attack or a nuclear accident such as Chernobyl.
Some of the compounds, including the drug rapamycin, have previously been shown to extend life in organisms such as worms and flies, though it’s unknown if they would have the same benefit in humans. UVA’s research suggests that these compounds, or similar drugs, might counter the deadly effects of ionizing radiation.
Currently there is no treatment for people exposed to lethal doses of radiation; doctors can only try to ease their suffering until death. “If you’re exposed to a very, very high dose, it’s rapid deterioration and immediate death,” explained John S. Lazo, PhD, of UVA’s Department of Pharmacology. “It’s the lower doses that people – particularly governments – are concerned about. The type of exposure that might result from a dirty bomb or a nuclear accident. How do we alleviate the effects? What’s the antidote? Right now, we just don’t have anything.”
Lazo and his colleague Elizabeth R. Sharlow, PhD, screened a library of more than 3,400 existing drugs, vitamins and other compounds to identify ones that might help cells withstand the effects of radiation exposure. The goal was to keep stem cells – the cells that produce the various cell types in the body – alive long enough to repair the damage caused by radiation.
“We wanted to find already approved drugs that would potentially keep stem cells, or progenitor cells, alive after radiation exposure,” Sharlow said. “That’s very much of interest to the NIH [National Institutes of Health] right now: How can we keep those self-renewing populations alive so they can actually help heal the effects of radiation exposure?”
After they identified potential leads, Sharlow created 3D computer models to compare the substances’ chemical structures. That analysis identified a cluster of promising compounds with similar structures – a tantalizing lead in the quest for an antidote. “If you’re a drug hunter, the way we are, this is really cool information,” Lazo said. “Because you can say, ‘Now I will look in the universe of 40 million compounds. What else looks like that? Are they useful?'”
He noted that it is unlikely any one drug or compound will work on its own. “A lot of us in this field think it will be a cocktail of things you take,” he said. “And if you think you need cocktails, you need the individual ingredients. That’s why we think this is pretty important – because it’s providing new ingredients for that cocktail.”
The Latest on: Radiation antidote
[google_news title=”” keyword=”radiation antidote” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Radiation antidote
- Developing the next-generation of radiation safety professionalson September 29, 2023 at 11:35 am
UPTON, NY—To run any radiological facility, safety must be everyone’s highest priority. Having a team of specialists trained in radiation protection is essential to any work being done with ...
- University of Cincinnati radiation oncology experts present at national conferenceon September 28, 2023 at 5:00 pm
University of Cincinnati Cancer Center researchers will present abstracts at the American Society for Radiation Oncology (ASTRO) Annual Meeting, held Oct. 1-4 in San Diego. ...
- askST: iPhone 12 failed France’s radiation test. Is the device safe to use?on September 28, 2023 at 2:36 pm
Here’s what you need to know about the dispute in France, and whether the iPhone 12 is safe to use. Read more at straitstimes.com.
- ART Health Announces Construction of a State-of-the-Art Radiation Oncology Treatment Center Serving Greater Las Vegas, Nevadaon September 27, 2023 at 11:58 am
Advanced Radiotherapy Technologies ("ART Health"), a Kingsbarn company, has started construction of a state-of-the-art radiation treatment center in Henderson. The center is expected to open for ...
- Doctors’ union president apologises after saying incidents of sexual assault in medicine ‘not high’on September 26, 2023 at 9:26 pm
Dr Antony Sara says it is ‘unacceptable’ that sexual harassment ‘remains distressingly prevalent’ for doctors at work ...
- Radiation Shielding Material Market worth $980 million | MarketsandMarketson September 25, 2023 at 5:45 pm
"The Key players in the Medical Radiation Shielding market are ETS-LINDGREN (An Esco Technologies Company) (US), Nelco worldwide (US), Infab Corporation (US), Burlington Medical (US)"In the near ...
- Radiation therapy combined with two types of immunotherapy could be effective against cold tumorson September 25, 2023 at 5:37 pm
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy-;one that boosts T cells, and another that boosts dendritic cells-;can control ...
- Combination radiation with immunotherapy shows promise against 'cold' breast cancer tumorson September 25, 2023 at 1:05 pm
Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control ...
- New nuclear medicine factory to replace ageing site at Lucas Heights reactoron September 24, 2023 at 7:31 pm
The improved facility, where radioactive drugs used to diagnose cancer will be produced, will be built at the site of Australia’s only nuclear reactor, in southern Sydney.
- Time for Personalized Radiation Therapy inon September 21, 2023 at 11:23 am
Support for the study was provided by the Department of Radiation Oncology, Stanford University School of Medicine, and by the Global Center for Biomedical Science and Engineering, Hokkaido University ...
via Bing News